Liver transplantation for nonviral, nonmalignant diseases: Problem of recurrence

World Journal of Surgery

Volumn 26, Issue 2, 2002, Pages 247-256

  Renz, John F ^a,b   Ascher, Nancy L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; AGE; AGED; ALCOHOL LIVER DISEASE; ARTICLE; AUTOIMMUNE HEPATITIS; BUDD CHIARI SYNDROME; DIAGNOSIS RELATED GROUP; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; RECURRENT DISEASE; TREATMENT INDICATION; UNITED STATES; LIVER FAILURE; MIDDLE AGED; STATISTICS;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER DISEASES; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE;

EID: 0036482636     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-001-0213-2     Document Type: Article

References (134)

1. Starzl, T.E., Groth, C.G., Brettschneider, L., Moon, J.B., Fulginiti, V.A., Cotton, E.K., Porter, K.A.: Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery 63:549-563, 1968
2. Starzl, T.E., Giles, G., Lilly, J.R., Takagi, H., Martineau, G., Schroter, G., Halgrimson, C.G., Penn, I., Putnam, C.W.: Indications for orthotopic liver transplantation: with particular reference to hepatomas, biliary atresia, cirrhosis, Wilson's disease, and serum hepatitis. Transplant. Proc. 3:308-312, 1971
3. Lake, J.R.: Changing indications for liver transplantation. Gastroenterol. Clin. North Am. 22:213-229, 1993
4. Belle, S.H., Beringer, K.C., Detre, K.M.: Liver transplantation in the United States: Results from the national Pitt-UNOS liver transplant registry. In Terasaki, P.I., Cecka, J.M., editors, Clinical Transplants 1994, Los Angeles: UCLA Tissue Typing Laboratory, p. 19-35, 1995
5. Belle, S.H., Beringer, K.C., Detre, K.M.: An update on liver transplantation in the United States: recipient characteristics and outcome. In: Terasaki, P.I., Cecka, J.M. (eds). Clinical Transplants 1995. Los Angeles: UCLA Tissue Typing Laboratory, p.22-47, 1996
6. Teperman, L., Podesta, L., Mieles, L., Starzl, T.E.: The successful use of older donors for liver transplantation. J.A.M.A. 262:2837-2844, 1989
7. Mor, E., Klintmalm, G.B., Gonwa, T.A., Solomon, H., Holman, M.J., Gibbs, J.F., Watemberg, I., Goldstein, R.M., Husberg, B.S.: The use of marginal donors for liver transplantation. Transplantation 53:383-386, 1992
8. Sheiner, P.A., Mor, E., Schwartz, M.E., Miller, C.M.: The use of hepatitis C positive donors in liver transplantation. Transplant. Proc. 25:3071-3078, 1993
9. Broelsch, C.E., Whitington, P.F., Emond, J.C., Heffron, T.G., Thistlewaite, J.R., Stevens, L., Piper, J., Whitington, S.H., Lichtor, J.L.: Liver transplantation in children from living related donors. Ann. Surg. 214:428-439, 1991
10. Broelsch, C.E., Emond, J.C., Whitington, P.F., Thistlethwaite, J.R., Baker, A.L., Lichtor, J.L.: Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann. Surg. 212:368-377, 1990
11. Goss, J.A., Yersiz, H., Shackleton, C.R., Seu, P., Smith, C.V., Markowitz, J.S., Farmer, D.G., Ghobrial, R.M., Markmann, J.F., Arnaout, W.S., Busuttil, R.W.: In situ splitting of the cadaveric liver for transplantation. Transplantation 64:871-877, 1997
12. UNOS update: UNOS Scientific Registry, Rockville, MD, p. 14-36, 1994
13. Lo, C.M., Fan, S.T., Liu, C.L., Wei, W.I., Lo, R.J., Lai, C.L., Chan, J.K., Ng, I.O., Fung, A., Wong, J.: Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann. Surg. 226:261-269, 1997
14. Kawasaki, S., Makuuchi, M., Matsunami, H., Hashikura, Y., Ikegami, T., Nakazawa, Y., Chisuwa, H., Terada, M., Miyagawa, S.: Living related liver transplantation in adults. Ann. Surg. 227:269-274, 1998
15. UNOS update: UNOS Scientific Registry, Rockville, MD, p. 9-29, 1988
16. UNOS update: UNOS Scientific Registry, Rockville, MD, p. 11-32, 1996
17. Markmann, J.F., Markowitz, J.S., Yersiz, H., Morrisey, M., Farmer, D.G., Farmer, D.A., Goss, J., Ghobrial, R., McDiarmid, S.V., Stribling, R., Busuttil, R.W.: Long-term survival after retransplantation of the liver. Ann. Surg. 226:408-418, 1997
18. Jenkins, R.L., Pinson, C.W., Stone, M.D.: Experience with transplantation in the treatment of liver cancer. Cancer Chemother. Pharmacol. 23:S104-S109, 1989
19. Ringe, B., Wittekind, C., Bechstein, W.O., Bunzendahl, H., Pichlmayr, R.: The role of liver transplantation in hepatobiliary malignancy. Ann. Surg. 209:88-98, 1989
20. Philips, M.J., Cameron, R., Flowers, M.A., Blendis, L.M., Greig, P.D., Wanless, I., Sherman, M., Superina, R., Langer, B., Levy, G.A.: Post-transplant recurrent hepatitis B viral liver disease: viral-burden, steatoviral, and fibroviral hepatitis B. Am. J. Pathol. 140:1295-1308, 1992
21. Sallie, R., Cohen, A.T., Tibbs, C.J., Portmann, B.C., Rayner, A., O'Grady, J.G., Tan, K.C., Williams, R.: Recurrence of hepatitis C following orthotopic liver transplantation: a polymerase chain reaction and histologic study. J. Hepatol. 21:536-542, 1994
22. Ludwig, J., Batts, K.P., Moyer, T.P., Baldus, W.P., Fairbanks, V.F.: Liver biopsy diagnosis of homozygous hemochromatosis: a diagnostic algorithm. Mayo Clin. Proc. 68:263-267, 1993
23. Randall, H.B., Wachs, M.E., Somberg, K.A., Lake, J.R., Emond, J.C., Ascher, N.L., Roberts, J.P.: The use of T-tubes after orthotopic liver transplantation. Transplantation 61:258-261, 1996
24. Brown, R.S., Ascher, N.L., Lake, J.R., Emond, J.C., Bacchetti, P., Randall, H.B., Roberts, J.P.: The importance of surgical complications after liver transplantation on resource utilization. Arch. Surg. 132:1098-1103, 1997
25. Mitchell, B., Dayton, J.S., Turka, L.A., Thompson, C.B.: GTP depletion induced by IMP dehydrogenase inhibitors blocks RNA-primed DNA synthesis. Ann. N. Y. Acad. Sci. 685:217-225, 1993
26. St. Georgie, V.: Mycophenolate mofetil. Ann. N. Y. Acad. Sci. 685:207-211, 1993
27. Allison, A., Eugui, E.M.: Preferential suppression of lymphocyte proliferation by mycophenolic acid and predicted long-term effects of mycophenolate mofetil in transplantation. Transplant. Proc. 25:8-12, 1993
28. Sollinger, H., Deierhoi, M., Belzer, F.O., Diethelm, A.G., Kauffman, R.S.: The incidence of subsequent acute rejection following the treatment of refractory renal allograft rejection with mycophenolate mofetil. Transplantation 53:428-431, 1992
29. Morris, R., Wang, J.: Comparison of the immunosuppressive effect of mycophenolate mofetil and the morpholinoethyl ester of mycophenolic acid in recipients of heart allografts. Transplant. Proc. 23:493-498, 1991
30. Danovitch, G.M.: Mycophenolate mofetil in renal transplantation: results from the U.S. randomized trials. Kidney Int. 52:S93-S98, 1995
31. European Mycophenolate Mofetil Cooperative Study: Lancet 345: 1321-1324, 1995
32. Demetris, J.A., Seaberg, E.C., Batts, K.P., Ferrell, L.D., Ludwig, J., Markin, R.S., Belle, S.H., Detre, K.: Reliability and predictive value of the National Institute of Diabetes and Digestive and Kidney Diseases liver transplantation database nomenclature and grading system for cellular rejection of liver allografts. Hepatology 21:408-416, 1995
33. Mitchison, H.C., Lucey, M.R., Kelly, P.J., Neuberger, J.M., Williams, R., James, O.F.: Symptom development and prognosis in primary biliary cirrhosis: a study in two centers. Gastroenterology 99:778-784, 1990
34. Gores, G.J., Moore, S.B., Fisher, L.D., Powell, F.C., Dickson, E.R.: Primary biliary cirrhosis: association with class II major histocompatibility complex antigens. Hepatology 7:889-892, 1987
35. Culp, K.S., Fleming, C.R., Duffy, J., Baldus, W.P., Dickson, E.R.: Autoimmune association in primary biliary cirrhosis. Mayo Clin. Proc. 57:365-370, 1982
36. Roll, J., Boyer, J.L., Barry, D., Klatskin, G.: The prognostic importance of clinical and histological features in asymptomatic and symptomatic biliary cirrhosis. N. Engl. J. Med. 308:1-7, 1983
37. Christensen, E., Neuberger, J., Crowe, J., Portmann, B., Williams, R., Altman, D.G., Popper, H., Doniach, D., Ranek, L., Tygstrup, N.: Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Gastroenterology 89:1084-1091, 1985
38. Dickson, E.R., Grambsch, P.M., Fleming, T.R., Fischer, L.D., Langworthy, A.: Prognosis in primary biliary cirrhosis: a model for decision making. Hepatology 10:1-7, 1989
39. Polson, R.J., Portmann, F., Neuberger, J., Calne, R.Y., Williams, R.: Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis. Gastroenterology 97:715-725, 1989
40. Esquivel, C.O., Van Thiel, D.H., Demetris, A.J., Bernardos, A., Iwatsuki, S., Markus, B., Gordon, R.D., Marsh, J.W., Makowka, L., Tzakis, A.G., Starzl, T.E.: Transplantation for primary biliary cirrhosis. Gastroenterology 94:1207-1216, 1988
41. Balan, V., Batts, K.P., Porayko, M.K., Krom, R.A., Ludwig, J., Wiesner, R.H.: Histologic evidence for recurrence of primary biliary cirrhosis following liver transplantation. Hepatology 18:1392-1398, 1993
42. Neuberger, J., Portmann, B., MacDougall, B.R.D., Calne, R.Y., Williams, R.: Recurrence of primary biliary cirrhosis after liver transplantation. N. Engl. J. Med. 306:1-4, 1982
43. Fennel, R.H., Shikes, R.H., Vierling, J.M.: Relationship of pretransplant hepatobiliary disease to bile duct damage occurring in the liver allograft. Hepatology 3:84-89, 1983
44. Demetris, A.J., Markus, B.H., Esquivel, C., Van Thiel, D.H., Saidman, S., Gordon, R., Makowka, L., Sysyn, G.D., Strarzl, T.E.: Pathologic analysis of liver transplantation for primary biliary cirrhosis. Hepatology 4:939-947, 1988
45. Buist, L.J., Hubscher, S.G., Vickers, C., Michell, I., Neuberger, J., McMaster, P.: Does liver transplantation cure primary biliary cirrhosis? Transplant. Proc. 21:2402-2404, 1989
46. Samuel, D., Gugenheim, J., Mentha, G., Castaing, D., Degos, F., Benhamou, J.P., Bismuth, H.: Liver transplantation for primary biliary cirrhosis. Transplant. Proc. 22:1497-1498, 1998
47. Hart, J., Busuttil, R.W., Lewin, K.J.: Disease recurrence following liver transplantation. Am. J. Surg. Pathol. 14:79-91, 1990
48. Dietze, O., Vogel, W., Margreiter, R., Mikuz, G.: Early recurrence of primary biliary cirrhosis after liver transplantation. Gastroenterology 98:1106-1109, 1990
49. Hubscher, S.G., Elias, E., Buckels, J.A.C., Mayer, A.D., McMaster, P., Neuberger, J.M.: Primary biliary cirrhosis. J. Hepatol. 18:173-184, 1993
50. Gouw, A.S.H., Haagsma, E.B., Manns, M., Klompmaker, I.J., Sloof, M.J.H., Gerber, M.A.: Is there recurrence of primary biliary cirrhosis after liver transplantation? A clinicopathologic study in long-term survivors. J. Hepatol. 20:500-507, 1994
51. Van de Water, J., Gerson, L.B., Ferrell, L.D., Lake, J.R., Coppel, R.L., Batts, K.P., Wiesner, R.H., Gershwin, M.E.: Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis. Hepatology 24:1079-1084, 1996
52. Dmitrewski, J., Hubscher, S.G., Mayer, D., Neuberger, J.M.: Recur rence of primary biliary cirrhosis in the liver allograft: the effect of immunosuppression. J. Hepatol. 24:253-257, 1996
53. Kim, W.R., Poterucha, J.J., Jorgensen, R.A., Batts, K.P., Homburger, H.A., Dickson, E.R., Krom, R.A., Wiesner, R.H., Lindor, K.D.: Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis?, Hepatology 26:22-26, 1997
54. Neuberger, J.: Transplantation for primary biliary cirrhosis. Semin. Liver Dis. 17:137-146, 1997
55. Slapak, G.I., Saxena, R., Portmann, B., Gane, E., Devlin, J., Calne, R., Williams, R.: Graft and systemic disease in long-term survivors of liver transplantation. Hepatology 25:195-202, 1997
56. Crippin, J.S., Lindor, K.D.: Primary sclerosing cholangitis: etiology and immunology. Eur. J. Gastroenterol. Hepatol. 4:261-265, 1992
57. Farrant, J.M., Hayllar, K.M., Wilkinson, M., Karani, J., Portmann, B.C., Westaby, D., Williams, R.: Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 100: 1710-1717, 1991
58. Wiesner, R.H., Grambsch, P.M., Dickson, E.R., Ludwig, J., MacCarty, R.L., Hunter, E.B., Fleming, T.R., Fisher, L.D., Beaver, S.J., LaRusso, N.F.: Primary sclerosing cholangitis: natural history, prognostic factors, and survival analysis. Hepatology 10:430-436, 1989
59. Aadland, E., Schrumpf, E., Fausa, O., Elgjo, K., Heilo, A., Aakhus, T., Gjone, E.: Primary sclerosing cholangitis: a long-term follow-up study. Scand. J. Gastroenterol. 22:655-664, 1987
60. Johnson, G.K., Geenan, J.E., Venu, R.P., Schmalz, M.J., Hogan, W.J.: Endoscopic treatment of biliary tract strictures in sclerosing cholangitis: a large series and recommendations for treatments. Gastrointest. Endosc. 37:38-43, 1991
61. Gaing, A.A., Geders, J.M., Cohen, S.A., Siegal, J.H.: Endoscopic management of primary sclerosing cholangitis: review, and report of an open series. Am. J. Gastroenterol. 88:2000-2008, 1993
62. Lee, J.G., Schutz, S.M., England, R.E., Leung, J.W., Cotton, P.B.: Endoscopic therapy of sclerosing cholangitis. Hepatology 21:661-667, 1995
63. Chapman, R.W.G., Arborgh, B.A., Rhodes, J.M., Summerfield, J.A., Dick, R., Scheuer, P.J., Sherlock, S.: Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 21:870-877, 1980
64. Rosen, C.B., Nagorney, D.M., Wiesner, R.H., Coffey, R.J., Jr., LaRusso, N.F.: Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann. Surg. 213:21-25, 1991
65. Knechtle, S.J., D'Alessandro, A.M., Harms, B.A., Pirch, J.D., Belzer, F.O., Kalayoglu, M.: Relationship between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation. Surgery 118:615-620, 1995
66. Abu-Elmegd, K.M., Selby, R., Iwatsuki, S., Fung, J., Tzakis, A., Todo, S., Demetris, A.J., Baddour, N., Irish, W., Van Thiel, D.H., Starzl, T.E.: Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after liver transplantation. Transplant. Proc. 25:1124-1129, 1993
67. Lee, Y.M., Kaplan, M.M.: Primary sclerosing cholangitis. N. Engl. J. Med. 332:924-933, 1995
68. Narumi, S., Roberts, J.P., Emond, J.C., Lake, J., Ascher, N.L.: Liver transplantation for sclerosing cholangitis. Hepatology 22:451-457, 1995
69. Lerut, J., Demetris, A.J., Stieber, A.C., Marsh, J.W., Gordon, R.D., Esquivel, C.O., Iwatsuki, S., Starzl, T.E.: Intrahepatic bile duct strictures after human orthotopic liver transplantation: recurrence of primary sclerosing cholangitis or unusual presentation of allograft rejection?. Transpl. Int. 1:127-130, 1988
70. Hunter, E.B., Wiesner, R.H., MacCarty, R.L.: Does primary sclerosing cholangitis recur after liver transplantation? Gastroenterology 96:A610-A614, 1989
71. Ahrendt, S.A., Pitt, H.A., Kalloo, A.N., Venbrux, A.C., Klein, A.S., Herlong, H.F., Coleman, J., Lillemoe, K.D., Cameron, J.L.: Primary sclerosing cholangitis: resect, dilate, or transplant?. Ann. Surg. 227: 412-423, 1998
72. National Institutes of Health Consensus Development Conference Statement: Liver transplantation - June 20-23, 1983. Hepatology 7:107S-110S, 1984
73. Donovan, C.L., Marcovitz, P.A., Punch, J.D., Bach, D.S., Brown, K.A., Lucey, M.R.: Two-dimensional and dobutamine stress echocardiography in the pre-operative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation. Transplantation 61:1180-1188, 1996
74. Kumar, S., Stauber, R.E., Gavaler, J.S., Basista, M.H., Dindzans, V.J., Schade, R.R.: Orthotopic liver transplantation for alcoholic liver disease. Hepatology 11:159-164, 1990
75. Lucey, M.R., Merion, R.M., Henley, K.S., Campbell, D.A. Jr., Turcotte, J.G., Nostrant, T.T.: Selection for and outcome of liver transplantation in alcoholic liver disease. Gastroenterology 102:1736-1741, 1992
76. Gish, R.G., Lee, A.H., Keefe, E.B., Rome, H., Concepcion, W., Esquivel, C.O.: Liver transplantation for patients with alcoholism and end-stage liver disease. Am. J. Gastroenterol. 88;1337-1342, 1993
77. Lucey, M.R.: Medical assessment of alcoholic candidates for liver transplantation. In Liver Transplantation and the Alcoholic Patient. Medical Surgical and Psychosocial Issues. Lucey, M.R., Merion, R.M., Beresford, T.P., editors, Cambridge, UK, Cambridge University Press, 1994, p. 113-130
78. Beresford, T.P.: Psychiatric assessment of alcoholic candidates for liver transplantation. In Liver Transplantation and the Alcoholic Patient, Medical Surgical and Psychosocial Issues, Lucey, M.R., Merion, R.M., Beresford, T.P. (eds). Cambridge, UK, Cambridge University Press, 1994, p. 29-49
79. Grant, B.F., Debakey, S., Zobeck, T.S.: Surveillance report 18. Liver cirrhosis mortality in the United States, 1973-1988, Rockville, MD, National Institute on Alcohol Abuse and Alcoholism, Division of Biometry and Epidemiology, US Department of Health and Human Services, 1991, p. 11-24
80. Grant, B.F., Harford, T.C., Dawson, D.A., Chou, P., Dufour, M., Pickering, R.S.: Prevalence of DSM-IV alcohol abuse and dependence - United States, 1992. Alcohol Health Res. World 183:243-248, 1991
81. Campbell, D.A., Jr., Lucey, M.R.: Liver transplantation for alcoholic cirrhosis. In Transplantation of the Liver, Busuttil, R.W., Klintmalm, G.B., editors, Philadelphia, W.B. Saunders, 1996, p. 145-150
82. Hoofnagle, J.H., Kresina, T., Fuller, R.K., Lake, J.R., Lucey, M.R., Sorrell, M.F., Beresford, T.P.: Liver transplantation for alcoholic liver disease: executive statement and recommendations. Liver Transpl. Surg. 3:347-350, 1997
83. Starzl, T.E., Van Thiel, D., Tzakis, A.G., Iwatsuki, S., Todo, S., Marsh, J.W.: Orthotopic liver transplantation for alcoholic cirrhosis. J.A.M.A. 260:2542-2544, 1998
84. Kumar, S., Stauber, R.E., Gavaler, J.S., Basista, M.H., Dindzans, V.J., Schade, R.R.: Orthotopic liver transplantation for alcoholic liver disease. Hepatology 11:159-164, 1990
85. Bird, G.L.A., O'Grady, J.G., Harvey, F.A.H., Calne, R.Y., Williams, R.: Liver transplantation in patients with alcoholic cirrhosis: selection criteria and rates of survival and relapse. Br. Med. J. 301:15-17, 1990
86. Knechtle, S.J., Fleming, M.F., Barry, K.L., Steen, D., Pirsch, J.D., Hafez, G.R.: Liver transplantation for alcoholic liver disease. Surgery 112:694-701, 1992
87. Berlakovich, G.A., Steininger, R., Herbst, F., Barlan, M., Mittlbock, M., Muhlbacher, F.: Efficacy of liver transplantation for alcoholic cirrhosis with respect to recidivism and compliance. Transplantation 58:560-565, 1994
88. Howard, L., Fahy, T., Wong, P., Sherman, D., Gane, E., Williams, R.: Psychiatric outcome in alcoholic liver transplant patients. Q. J. Med. 87:731-736, 1994
89. Krom, R.A.F.: Liver transplantation and alcohol: who should get transplants?. Hepatology 20:28S-32S, 1994
90. Osorio, R.W., Ascher, N.L., Avery, M., Bacchetti, P., Roberts, J.P., Lake, J.R.: Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease. Hepatology 20:105-110, 1994
91. Poynard, T., Barthelemy, P., Fratte, S., Boudjema, K., Doffoel, M., Vanlemmens, C.: Evaluation of efficacy of liver transplantation in alcoholic cirrhosis by a case-control study and simulated controls. Lancet 344:502-507, 1994
92. Belle, S.H., Beringer, K.C., Detre, K.M.: Liver transplantation in the United States: results from the national Pitt-UNOS liver transplant registry. In Clinical Transplants, 1994, Terasaki, P., Cecka, M., editors, Los Angeles, UCLA Tissue Typing Laboratory, 1995, p. 19-35
93. Keeffe, E.B.: Assessment of the alcoholic patient for liver transplantation: comorbidity, outcome and recidivism. Liver Transpl. Surg. 2:12-20, 1996
94. Campbell, D.A., Jr., Punch, J.D.: Monitoring for alcohol use relapse after liver transplantation for alcoholic liver disease. Liver Transplant. Surg. 3:300-303, 1997
95. Everson, G., Bharadhwaj, G., House, R., Talamantes, M., Bilir, B., Shrestha, R., Kam, I., Wachs, M., Karrer, F., Fey, B., Ray, C., Steinberg, T., Morgan, C., Beresford, T.P.: Long-term follow-up of patients with alcoholic liver disease who underwent hepatic transplantation. Liver Transplant. Surg. 3:263-274, 1997
96. Everhart, J.E., Beresford, T.P.: Liver transplantation for alcoholic liver disease: a survey of transplantation programs in the United States. Liver Transplant. Surg. 3:220-226, 1997
97. Wiesner, R.H., Lombardero, M., Lake, J.R., Everhart, J., Detre, K.M.: Liver transplantation for end-stage alcoholic liver disease: an assessment of outcomes. Liver Transplant. Surg. 3:231-239, 1997
98. Yarze, J.C., Martin, P.: Liver transplantation for idiopathic autoimmune chronic active hepatitis. In Transplantation of the Liver, Busuttil, R.W., Klintmalm, G.B., editors, Philadelphia, W.B. Saunders, 1996, p. 113-119
99. Mistilis, S.P., Skyring, A.P., Blackburn, C.R.B.: Natural history of active chronic hepatitis I. Clinical features, course, diagnostic criteria, morbidity, mortality, and survival. Aust. Ann. Med. 17:214-223, 1968
100. Keating, J.J., O'Brien, C.J., Stellon, A.J., Portmann, B.C., Johnson, R.D., Johnson, P.J., Williams, R.: Influence of etiology, clinical, and histologic features on survival in chronic active hepatitis: an analysis of 204 patients. Q. J. Med. 237:59-66, 1987
101. Davis, G., Czaja, A.J., Baggenstoss, A.H., Taswell, H.F.: Prognostic and therapeutic implications of extreme serum aminotransferase elevation in chronic active hepatitis. Mayo Clin. Proc. 57:303-309, 1982
102. Sanchez-Urdazpal, L., Czaja, A.J., Rakela, J., Ludwig, J.: Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis. Hepatology 15:215-220, 1992
103. Czaja, A.J., Rakela, J., Ludwig, J.: Features reflective of early prognosis in cortico-steroid-treated severe autoimmune chronic active hepatitis. Gastroenterology 95:448-453, 1988
104. Czaja, A.J.: Natural history, clinical features, and treatment of autoimmune hepatitis. Semin. Liver Dis. 4:1-12, 1984
105. Donaldson, P.T., Doherty, D.G., Hayllor, K.M., McFarlane, I.G., Johnson, P.J., Williams, R.: Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 13:701-706, 1991
106. Maddrey, W.C., Friedman, L.S., Munoz, S.J., Hahn, E.G.: Selection of the patient for liver transplantation and timing of surgery. In Transplantation of the Liver, Maddrey, W.C., editor, New York, Elsevier, 1988, p. 23-58
107. Zimmerman, H.J., Heller, P., Hill, R.P.: Extreme hyperglobulinemia in subacute hepatic necrosis. N. Engl. J. Med. 244:245-249, 1951
108. Wood, J.R., Czaja, A.J., Beaver, S.J., Hall, S., Ginsburg, W.W., Kaufman, D.K.: Frequency and significance of antibody to double-stranded DNA in severe chronic active hepatitis. Hepatology 6:976-980, 1986
109. Konikoff, F., Isenberg, D.A., Barrison, I., Theodur, E., Shoenfeld, Y.: Antinuclear auto-antibodies in chronic liver diseases. Hepatogastroenterology 36:341-345, 1989
110. Dighiero, G., Lymberi, P., Monot, C., Abuaf, N.: Sera with high levels of anti-smooth muscle and anti-mitochondrial antibodies frequently bind to cytoskeletal proteins. Clin. Exp. Immunol. 82:52-56, 1990
111. Wright, H.L., Bou-Abboud, C.F., Hassanein, T., Block, G.D., Demetris, A.J., Starzl, T.E., van Thiel, D.: Disease recurrence and rejection following liver transplantation for autoimmune chronic active liver disease. Transplantation 53:136-139, 1992
112. Neuberger, J., Portmann, B., Calne, R., Williams, R.: Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting. Transplantation 37:363-365, 1984
113. Hemming, A., W., Langer, B., Greig, P., Taylor, B.R., Adams, R., Heathcote, E.J.: Treatment of Budd-Chiari syndrome with portosystemic shunt or liver transplantation. Am. J. Surg. 171:176-181, 1996
114. Shaked, A., Goldstein, R.: Transplantation for Budd-Chiari syndrome. In Transplantation of the Liver, Busuttil, R.W., Klintmalm, G.B., editors, Philadelphia, W.B. Saunders, 1996, p. 138-144
115. Tilanus, H.W.: Budd-Chiari syndrome. Br. J. Surg. 82:1023-1030, 1995
116. Knoop, M., Lemmens, H.P., Langrehr, J.M., Bechstein, W.O., Blumhardt, G., Schattenfroh, N., Keck, H., Neuhaus, P.: Liver transplantation for Budd-Chiari. Transplant. Proc. 26:3577-3578, 1994
117. Ringe, B., Lang, H., Oldhafer, K., Gebel, M., Flemming, P., Georgh, A., Borst, H., Pichlmayr, R.: Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients. Hepatology 21:1337-1344, 1995
118. Ahn, S., S., Yellin, A., Sheng, F.C., Colonna, J.O., Goldstein, L.I., Busuttil, R.W.: Selective surgical therapy of the BCS provides superior rates than conservative medical treatment. J. Vasc. Surg. 5:28-37, 1987
119. Sholar, P.W., Von Heerdan, J.A., Adson, M.A.: The BCS: Medical and surgical management of 30 patients. Arch. Surg. 120:657-662, 1985
120. Greenwood, L.H., Yrizarry, J.M., Hallett, J.W., Scoville, G.S.: Urokinase treatment for the BCS. American Journal of Roentengenology 141:1057-1059, 1983
121. Knoop, M., Lemmens, H.P., Bechstein, W.O., Blumhardt, G., Schattenfroh, N., Keck, H., Neuhaus, P.: Treatment of the Budd-Chiari syndrome with orthotopic liver transplantation and long-term anticoagulation. Clin. Transplant. 8:67-72, 1994
122. Panis, Y., Belghiti, J., Valla, D., Benhamou, J.P., Fekete, F.: Portosystemic shunt in Budd-Chiari syndrome: long-term survival and factors affecting shunt patency in 25 patients in Western countries. Surgery 115:276-281, 1994
123. Orloff, M.J., Orloff, M.S., Daily, P.O.: Long-term results of treatment of BCS with portal decompression. Arch. Surg. 127:1182-1188, 1992
124. Klein, A.S., Sitzmann, J.V., Coleman, J., Herlong, F.H., Cameron, J.L.: Current management of the BCS. Ann. Surg. 212:144-149, 1990
125. Lopez, R.R., Benner, K.G., Hall, L., Rosch, J., Pinson, C.W.: Expandable venous stents for the treatment of BCS. Gastroenterology 100:1435-1441, 1991
126. Shrestha, R., Durham, J.D., Wachs, M., Bilir, B.M., Kam, I., Trouillot, T., Everson, G.T.: Use of transjugular intrahepatic portosystemic shunt as a bridge to transplantation in fulminant hepatic failure due to Budd-Chiari syndrome. American Journal of Gastroenterology 92:2304-2306, 1997
127. Ochs, A., Sellinger, M., Haag, K., Noldge, G., Herbst, E.W., Walter, E., Gerok, W., Rossle, M.: Transjugular intrahepatic portosystemic stent-shunt (TIPS) in the treatment of Budd-Chiari syndrome. J. Hepatol. 18:217-225, 1993
128. Martin, L., Dondelinger, R.F., Trotteur, G.: Treatment of Budd-Chiari syndrome by metallic stent as a bridge to liver transplantation. Cardiovasc. Intervent. Radiol. 18:196-199, 1995
129. Wilson, M.W., Ring, E.J., LaBerge, J.M., Kerlan, R.K., Gordan, R.L.: Percutaneous transhepatic venography in the delineation and treatment of Budd-Chiari syndrome. Cardiovascular Intervent. Radiol. 7:133-138, 1996
130. Coldwell, D.M., Ring, E.J., Rees, C.R., Zemel, G., Darcy, M.D., Haskal, Z.J., McKusick, M.A., Greenfield, A.J.: Multicenter investigation of the role of transjugular intrahepatic portosystemic shunts in the management of portal hypertension. Radiology 196:335-340, 1995
131. Kuo, P.C., Johnson, L.B., Hastings, G., Pais, O., Plotkin, J.S., Orens, J.B., Howell, C.D., Lewis, D., Bartlett, S.T.: Fulminant hepatic failure from the Budd-Chiari syndrome, Transplantation 62:294-296, 1996
132. Campbell, D.A., Rolles, K., Jamison, N., O'Grady, J., Wight, D., Williams, R., Calne, R.: Hepatic transplantation with perioperative and long-term anticoagulation as a treatment for Budd-Chiari syndrome. Surg. Gynecol. Obstet. 166:511-518, 1988
133. Portman, B., O'Grady, J., Williams, R.: Disease recurrence following orthotopic liver transplantation. Transplant. Proc. 18 Suppl 4):136-141, 1986
134. Seltman, H.J., Dekker, A., van Thiel, D.H., Boggs, D.R., Starzl, T.E.: Budd-Chiari syndrome recurring in a transplanted liver. Gastroenterology 84:640-643, 1983